Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Dyslipidemias and stroke prevention: Recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology
E.J. Palacio-Portilla; J. Roquer; S. Amaro; J.F. Arenillas; O. Ayo-Martín; M. Castellanos; M.M. Freijo; B. Fuentes; A. García-Pastor; M. Gomis; M. Gómez-Choco; E. López-Cancio; P. Martínez-Sánchez; A. Morales; M. Rodríguez-Yáñez; T. Segura; J. Serena; J. Vivancos-Mora; M.A. de Leciñana;
Neurologia. 2022;37:61-72
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance
A. Gil-Núñez; J. Masjuan; J. Montaner; M. Castellanos; T. Segura; P. Cardona; J.I. Tembl; F. Purroy; J. Arenillas; E. Palacio;
Neurologia. 2022;37:136-50
Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease
J. Masjuan; J. Gállego; J.M. Aguilera; J.F. Arenillas; M. Castellanos; F. Díaz; J.C. Portilla; F. Purroy;
Neurologia. 2021;36:1-8